Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC)

Radiother Oncol. 2019 Jan:130:191-192. doi: 10.1016/j.radonc.2018.08.014. Epub 2018 Sep 21.

Authors

Jens Overgaard¹, Jan Alsner²

Affiliations

¹ Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. Electronic address: jens@oncology.au.dk.
² Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark.

PMID: 30249347
DOI: 10.1016/j.radonc.2018.08.014

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Squamous Cell*
Darbepoetin alfa
Denmark
Head and Neck Neoplasms*
Humans
Squamous Cell Carcinoma of Head and Neck*

Substances

Darbepoetin alfa